sphingosine

sphingosine is a lipid of Sphingolipids (SP) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 26061 references associated with sphingosine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for sphingosine

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with sphingosine

Download all related citations
Per page 10 20 50 100 | Total 6563
Authors Title Published Journal PubMed Link
Maciejek Z et al. Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report. Neurol. Neurochir. Pol. pmid:23650003
Yamasaki T et al. Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts. Cell Transplant pmid:9710310
Krieger S Multiple sclerosis therapeutic pipeline: opportunities and challenges. Mt. Sinai J. Med. pmid:21425264
Derwenskus J Current disease-modifying treatment of multiple sclerosis. Mt. Sinai J. Med. pmid:21425262
Huizinga R and Voyer T New paradigms in immunosuppression. CANNT J pmid:14596200
Li XK et al. Induction of lymphocyte apoptosis by a novel immunosuppressant FTY720: relation with Fas, Bcl-2 and Bax expression. Transplant. Proc. pmid:9123299
Li XK et al. FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecular ICAM-1 in TNF-alpha treated human umbilical vein endothelial cells. Transplant. Proc. pmid:9123298
Hussar DA and Zimmerman DE New drugs: dabigatran etexilate mesylate, fingolimod hydrochloride, and ulipristal acetate. J Am Pharm Assoc (2003) pmid:21247838
Pruvost R and Le Stunff H [Sphingosine kinase-1: role in non alcoholic fatty liver disease]. Med Sci (Paris) pmid:27615179
Harrison K Fingolimod for multiple sclerosis: a review for the specialist nurse. Br J Nurs pmid:24933548
Yopp AC et al. Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants. Clin Transplant pmid:17100731
Francois M et al. Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis. Pharm Stat pmid:22888087
Fujino M et al. T-cell apoptosis triggered by FTY720 via mitochondrial pathway. Transplant. Proc. pmid:11750325
Kahan BD FTY720: a new dimension in transplantation. Transplant. Proc. pmid:11750324
Kelly-Laubscher RF et al. Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. Cardiovasc J Afr pmid:25000441
Chun J and Hartung HP Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol pmid:20061941
Tabasinezhad M et al. Sphingosin 1-phosphate contributes in tumor progression. J Cancer Res Ther pmid:24518696
Sauro S et al. Di-Calcium Phosphate and Phytosphingosine as an Innovative Acid-Resistant Treatment to Occlude Dentine Tubules. Caries Res. pmid:27179116
Lu W et al. Improved Proliferation and Differentiation of Bone Marrow Mesenchymal Stem Cells Into Vascular Endothelial Cells With Sphingosine 1-Phosphate. Transplant. Proc. pmid:26293094
Kunikata S et al. Immunosuppressive action of FTY720 for renal allograft a rat model. Transplant. Proc. pmid:10083517